ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,140.86
0.05%
Dow Jones
42,962.66
-0.84%
Gold vs US Dollar
2,617.59
-0.58%
Brent Oil
73.455
0.78%
Bitcoin
94,514.95
-1.21%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. C4 Therapeutics Inc (CCCC)

  7. C4 Therapeutics Inc (CCCC) News

C4 Therapeutics (CCCC)

C4 Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CCCC
DateTimeSourceHeadlineSymbolCompany
09/12/202414:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
08/12/202417:30GlobeNewswire Inc.C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 DegraderNASDAQ:CCCCC4 Therapeutics Inc
20/11/202412:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
20/11/202412:00GlobeNewswire Inc.C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of DirectorsNASDAQ:CCCCC4 Therapeutics Inc
18/11/202421:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CCCCC4 Therapeutics Inc
15/11/202421:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CCCCC4 Therapeutics Inc
15/11/202421:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CCCCC4 Therapeutics Inc
14/11/202421:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
14/11/202420:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
14/11/202420:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
14/11/202414:01Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
14/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CCCCC4 Therapeutics Inc
14/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CCCCC4 Therapeutics Inc
13/11/202421:58Edgar (US Regulatory)Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]NASDAQ:CCCCC4 Therapeutics Inc
13/11/202421:57Edgar (US Regulatory)Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]NASDAQ:CCCCC4 Therapeutics Inc
12/11/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
12/11/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
12/11/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
12/11/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
06/11/202412:00GlobeNewswire Inc.C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical TrialNASDAQ:CCCCC4 Therapeutics Inc
05/11/202414:00GlobeNewswire Inc.C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual MeetingNASDAQ:CCCCC4 Therapeutics Inc
31/10/202421:27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CCCCC4 Therapeutics Inc
31/10/202421:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CCCCC4 Therapeutics Inc
31/10/202411:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CCCCC4 Therapeutics Inc
31/10/202411:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
31/10/202411:00GlobeNewswire Inc.C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CCCCC4 Therapeutics Inc
29/10/202420:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
29/10/202420:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
28/10/202420:01GlobeNewswire Inc.C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CCCCC4 Therapeutics Inc
22/10/202422:06Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CCCCC4 Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CCCC

Your Recent History

LSE
SYME
Supply@me Capital
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
ZED
Zenova
LSE
GEX
Georgina Energy
LSE
UPS
LSE
TRP
Tower Resources
LSE
GDR
Genedrive
LSE
RPI
Raspberry Pi
LSE
SRT
Srt Marine Systems
LSE
VTY
Vistry
LSE
BIRD
Blackbird
LSE
BARC
Barclays
LSE
ZEN
Zenith Energy
LSE
LLOY
Lloyds Banking
LSE
UJO
Union Jack Oil
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads